Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-03 5:22 pm Purchase |
2021-02-01 | 13G | Ignyte Acquisition Corp. IGNYU |
James E. Flynn | 725,000 11.420% |
725,000 (New Position) |
Filing History |
| 2021-01-08 3:32 pm Unchanged |
2021-01-05 | 13D | Protara Therapeutics, Inc. TARA |
James E. Flynn | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-12-17 10:56 am Purchase |
2020-12-11 | 13G | Delcath Systems, Inc. DCTH |
James E. Flynn | 500,000 8.750% |
500,000 (New Position) |
Filing History |
| 2020-12-08 4:12 pm Purchase |
2020-11-23 | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU |
James E. Flynn | 500,000 5.950% |
500,000 (New Position) |
Filing History |
| 2020-11-24 5:18 pm Purchase |
2020-11-16 | 13G | Itamar Medical Ltd. ITMR |
James E. Flynn | 23,814,090 5.610% |
23,814,090 (New Position) |
Filing History |
| 2020-11-20 3:59 pm Unchanged |
2020-11-12 | 13D | Graybug Vision, Inc. GRAY |
James E. Flynn | 377,265 25.180% |
0 (Unchanged) |
Filing History |
| 2020-10-30 11:42 am Purchase |
2020-10-20 | 13G | TURMERIC ACQUISITION CORP UNIT TMPMU |
James E. Flynn | 750,000 7.360% |
750,000 (New Position) |
Filing History |
| 2020-10-30 11:39 am Purchase |
2020-10-27 | 13G | Eucrates Biomedical Acquisition Corp. EUCRU |
James E. Flynn | 1,000,000 7.780% |
1,000,000 (New Position) |
Filing History |
| 2020-10-26 5:08 pm Purchase |
2020-10-16 | 13G | Meridian Bioscience, Inc. VIVO |
James E. Flynn | 2,369,166 5.530% |
2,369,166 (New Position) |
Filing History |
| 2020-10-16 12:22 pm Purchase |
2020-10-06 | 13D | Oncorus, Inc. ONCR |
James E. Flynn | 2,848,970 13.040% |
2,848,970 (New Position) |
Filing History |
| 2020-10-09 3:51 pm Purchase |
2020-09-29 | 13D | Graybug Vision, Inc. GRAY |
James E. Flynn | 377,265 26.290% |
377,265 (New Position) |
Filing History |
| 2020-10-09 3:29 pm Purchase |
2020-10-05 | 13G | Nuo Therapeutics, Inc. AURX |
James E. Flynn | 2,700,000 9.240% |
2,700,000 (New Position) |
Filing History |
| 2020-09-29 4:06 pm Purchase |
2020-09-18 | 13G | Metacrine, Inc. MTCR |
James E. Flynn | 927,469 3.580% |
927,469 (New Position) |
Filing History |
| 2020-09-21 4:41 pm Purchase |
2020-09-09 | 13D | HIGHCAPE CAP ACQUISITION CRP U CAPAU |
James E. Flynn | 1,000,000 8.400% |
1,000,000 (New Position) |
Filing History |
| 2020-08-20 4:17 pm Purchase |
2020-08-10 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 4,775,916 17.140% |
4,775,916 (New Position) |
Filing History |
| 2020-08-10 4:58 pm Purchase |
2020-07-31 | 13G | OraSure Technologies, Inc. OSUR |
James E. Flynn | 3,471,600 4.850% |
3,471,600 (New Position) |
Filing History |
| 2020-08-10 2:52 pm Purchase |
2020-08-07 | 13G | Puma Biotechnology, Inc. PBYI |
James E. Flynn | 2,278,153 5.740% |
2,278,153 (New Position) |
Filing History |
| 2020-08-06 10:58 am Purchase |
2020-07-28 | 13G | Inozyme Pharma, Inc. INZY |
James E. Flynn | 1,150,299 5.150% |
1,150,299 (New Position) |
Filing History |